Evidence map›Paper›PMID 32053595›Full record

ArticlePLoS genetics2020

NCBP2 modulates neurodevelopmental defects of the 3q29 deletion in Drosophila and Xenopus laevis models.

Mayanglambam Dhruba Singh, Matthew Jensen, Micaela Lasser, Emily Huber, Tanzeen Yusuff, Lucilla Pizzo, Brian Lifschutz, Inshya Desai, Alexis Kubina, Sneha Yennawar and 5 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 53 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Flynotyper 2.0: An updated tool for rapid quantitative assessment ofbioRxiv : the preprint server for biology · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Identification of potential pathways and biomarkers linked to progression in ALS.Annals of clinical and translational neurology · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Mayanglambam Dhruba SinghDepartment of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, Pennsylvania, United States of America.ORCID 0000-0003-2419-5888
Matthew JensenDepartment of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, Pennsylvania, United States of America.ORCID 0000-0002-5153-8543
Micaela LasserDepartment of Biology, Boston College, Chestnut Hill, Massachusetts, United States of America.
Emily HuberDepartment of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, Pennsylvania, United States of America.ORCID 0000-0003-0123-7141
Tanzeen YusuffDepartment of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, Pennsylvania, United States of America.ORCID 0000-0002-5601-9208
Lucilla PizzoDepartment of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, Pennsylvania, United States of America.ORCID 0000-0001-9325-7283
Brian LifschutzDepartment of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, Pennsylvania, United States of America.ORCID 0000-0002-9730-6094
Inshya DesaiDepartment of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, Pennsylvania, United States of America.
Alexis KubinaDepartment of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, Pennsylvania, United States of America.
Sneha YennawarDepartment of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, Pennsylvania, United States of America.
Sydney KimDepartment of Biology, Boston College, Chestnut Hill, Massachusetts, United States of America.
Janani IyerDepartment of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, Pennsylvania, United States of America.ORCID 0000-0003-0666-9744
Diego E Rincon-LimasDepartment of Neurology, McKnight Brain Institute, University of Florida, Gainesville, Florida, United States of America.ORCID 0000-0003-3099-0642
Laura Anne LoweryDepartment of Biology, Boston College, Chestnut Hill, Massachusetts, United States of America.ORCID 0000-0001-8959-2679
Santhosh GirirajanDepartment of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, Pennsylvania, United States of America.ORCID 0000-0003-0598-4945
Pennsylvania State University · USBoston College · USUniversity of Florida · US

Funding

Genomic basis of phenotypic variability of genomic disordersR01GM121907 · NIGMS · PENNSYLVANIA STATE UNIVERSITY, THE · PI GIRIRAJAN, SANTHOSH · 2017 to 2025
$5.2M
Elucidating mechanistic connections between guidance signaling, microtubule regulation, and growth cone steering: Diversity SupplementR01MH109651 · NIMH · BOSTON MEDICAL CENTER · PI Laura Anne LOWERY · 2016 to 2026
$4.3M
Computation, Bioinformatics, and Statistics (CBIOS) Training ProgramT32GM102057 · NIGMS · PENNSYLVANIA STATE UNIVERSITY, THE · PI CHIAROMONTE, FRANCESCA, GIRIRAJAN, SANTHOSH · 2013 to 2022
$2.7M
NIGMS NIH HHS R01 GM121907NIGMS NIH HHS T32 GM102057NIMH NIH HHS R01 MH109651
6 · The paper itself

Abstract

The 1.6 Mbp deletion on chromosome 3q29 is associated with a range of neurodevelopmental disorders, including schizophrenia, autism, microcephaly, and intellectual disability. Despite its importance towards neurodevelopment, the role of individual genes, genetic interactions, and disrupted biological mechanisms underlying the deletion have not been thoroughly characterized. Here, we used quantitative methods to assay Drosophila melanogaster and Xenopus laevis models with tissue-specific individual and pairwise knockdown of 14 homologs of genes within the 3q29 region. We identified developmental, cellular, and neuronal phenotypes for multiple homologs of 3q29 genes, potentially due to altered apoptosis and cell cycle mechanisms during development. Using the fly eye, we screened for 314 pairwise knockdowns of homologs of 3q29 genes and identified 44 interactions between pairs of homologs and 34 interactions with other neurodevelopmental genes. Interestingly, NCBP2 homologs in Drosophila (Cbp20) and X. laevis (ncbp2) enhanced the phenotypes of homologs of the other 3q29 genes, leading to significant increases in apoptosis that disrupted cellular organization and brain morphology. These cellular and neuronal defects were rescued with overexpression of the apoptosis inhibitors Diap1 and xiap in both models, suggesting that apoptosis is one of several potential biological mechanisms disrupted by the deletion. NCBP2 was also highly connected to other 3q29 genes in a human brain-specific interaction network, providing support for the relevance of our results towards the human deletion. Overall, our study suggests that NCBP2-mediated genetic interactions within the 3q29 region disrupt apoptosis and cell cycle mechanisms during development.

Indexed as

AnimalsApoptosisBrainCell CycleChromosome DeletionChromosomes, Human, Pair 3Developmental DisabilitiesDisease Models, AnimalDrosophila melanogasterDrosophila ProteinsEmbryonic DevelopmentEmbryo, NonmammalianFemaleGene Expression Regulation, DevelopmentalGene Knockdown TechniquesGene Regulatory NetworksCbp20 protein, DrosophilaDrosophila Proteinsncbp2 protein, XenopusNuclear Cap-Binding Protein ComplexXenopus Proteins

Identifiers

PMID32053595
PMCPMC7043793
OpenAlexW3005710579

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.